| Brennan, Paul Joseph |
International Agency For Res On Cancer
United States |
PROMINENT - IARC |
3OT2CA278681-01S1 |
|
|
| Brenner, Dean E. |
University Of Michigan At Ann Arbor
United States |
Early Phase Clinical Cancer Prevention Consortium |
5UG1CA242632-04 |
RFA-CA-19-031 (UG1 Clinical Trial Required) |
Donald Johnsey |
| Bride, Colleen M Mc |
Emory University
United States |
Testing a Low Cost Population- and Theory-Based Outreach Intervention to Engage Ovarian Cancer Survivors and their Close Relatives to Consider Genetic Services |
5U01CA240581-04 |
PAR-18-616 (U01 Clinical Trial Optional) |
|
| Brown, Austin L |
Baylor College Of Medicine
United States |
A Systems Epidemiology Approach for Predicting Methotrexate Neurotoxicity in Pediatric Acute Leukemia |
5R01CA272981-02 |
|
|
| Bruner, Deborah Watkins |
Nrg Oncology Foundation, Inc.
United States |
NRG Oncology NCORP Research Base |
5UG1CA189867-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Bryan, Angela |
University Of Colorado
United States |
Cannabis for Palliative Care in Cancer: A Placebo-controlled Randomized Trial of Full Spectrum Hemp-derived CBD/THC |
1R01CA284860-01 |
|
Brennan Streck, Ph.D., R.N., M.P.H. |
| Buchanan, Adam H |
Geisinger Clinic
United States |
Feasibility and Assessment of a Cascade Traceback Screening program - FACTS |
5U01CA240747-04 |
PAR-18-616 (U01 Clinical Trial Optional) |
|
| Buczynski, Matthew Wallace |
Virginia Polytechnic Inst And St Univ
United States |
Anti-nociceptive actions of CART II in chemotherapy-induced peripheral neuropathy |
1R01CA284075-01 |
|
Rachel Altshuler, Ph.D. |
| Bylund, Carma L. |
University Of Florida
United States |
Dignity Therapy for Older Cancer Patients: Identifying Mechanisms and Moderators |
5R01CA253330-03 |
|
|
| Cantuaria, Guilherme |
Northside Hospital Atlanta
United States |
Georgia NCI Community Oncology Research Program (GA NCORP) |
5UG1CA189997-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |